FRIDAY 8 OCTOBER 2021 | 10th Trends in Medical Mycology

09:00

ECMM council meeting

12:00

Coffee break

Plenary Session 1 The 10th TIMM Anniversary

Chairs: Neil Gow, UK, FECMM & Martin Honigl, Austia, FECMM

12:30

PS 1.1 Achievements in the mycology laboratory

Sybren de Hoog, The Netherlands, FECCM

12:50

PS 1.2 Highlights of clinical trials in medical mycology

George Petrikkos, Greece

13:10

PS 1.3 Celebration of Fungal Facts and Science

Adilia Warris, UK, FECMM

13:45

Parallel Symposia 1-4

Symposium 1 Diagnostics Endemic Mycoses

Chairs: Nelesh Govender, South Africa, FECMM & Tadeja Matos, Slovenia

13:45

S01.1 Coccidioidomycosis

George Thompson, USA

14:05

S01.2 Talaromycosis

Thuy Le, USA

14:25

S01.3 Histoplasmosis

Alessandro Pasqualotto, Brazil’, FECMM

Symposium 2 Engaging the public - medical mycology advocacy, policy and the general public

Chairs: Donna MacCallum, UK & Esther Segal, Israel, FECMM

13:45

S02.1 discuss engaging general public

Lorna Barnes, UK

14:05

S02.2 advocacy, policy

David Denning, UK, FECCM

14:25

S02.3 engaging public and politics in Low Middle Income Countries

Bright Ocansey, UK

Symposium 3 Clinical Risk and prevention of IFI in patients receiving biologics and targeted therapies

Chair: Deborah Lockhart, UK

13:45

S03.1 Which drugs and clinical situations really increases the risk?

Jose Aguado, Spain, FECMM

14:05

S03.2 Is antifungal prophylaxis necessary?

14:25

S03.3 Biologic and targeted therapies for the treatment of IFI

Symposium 4 Update on new antifungals

Chairs: Oliver Cornely, Germany, FECMM & Martin Hoenigl, Austria, FECMM

13:45

4.1 Fosmanogepix

Michael Hodges, US

14:05

PC945

Lance Berman, UK

14:25

Ibrexafungerp

Nkechi Azie, US

14:45

NP339

Deborah A. O’Neil, UK

15:05

Targets for new antifungals

Haran Schlamm, US

15:15

Coffee break

15:30